Literature DB >> 27466180

SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2.

Elizabeth A Fogarty1, Megan H Brewer2, Jose F Rodriguez-Molina3, William D Law2, Ki H Ma3, Noah M Steinberg2, John Svaren4,5, Anthony Antonellis6,2,7.   

Abstract

Schwann cells are the myelinating glia of the peripheral nervous system and dysfunction of these cells causes motor and sensory peripheral neuropathy. The transcription factor SOX10 is critical for Schwann cell development and maintenance, and many SOX10 target genes encode proteins required for Schwann cell function. Loss-of-function mutations in the gene encoding myotubularin-related protein 2 (MTMR2) cause Charcot-Marie-Tooth disease type 4B1 (CMT4B1), a severe demyelinating peripheral neuropathy characterized by myelin outfoldings along peripheral nerves. Previous reports indicate that MTMR2 is ubiquitously expressed making it unclear how loss of this gene causes a Schwann cell-specific phenotype. To address this, we performed computational and functional analyses at MTMR2 to identify transcriptional regulatory elements important for Schwann cell expression. Through these efforts, we identified an alternative, SOX10-responsive promoter at MTMR2 that displays strong regulatory activity in immortalized rat Schwann (S16) cells. This promoter directs transcription of a previously unidentified MTMR2 transcript that is enriched in mouse Schwann cells compared to immortalized mouse motor neurons (MN-1), and is predicted to encode an N-terminally truncated protein isoform. The expression of the endogenous transcript is induced in a heterologous cell line by ectopically expressing SOX10, and is nearly ablated in Schwann cells by impairing SOX10 function. Intriguingly, overexpressing the two MTMR2 protein isoforms in HeLa cells revealed that both localize to nuclear puncta and the shorter isoform displays higher nuclear localization compared to the longer isoform. Combined, our data warrant further investigation of the truncated MTMR2 protein isoform in Schwann cells and in CMT4B1 pathogenesis.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27466180      PMCID: PMC5291229          DOI: 10.1093/hmg/ddw233

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  49 in total

1.  Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells.

Authors:  Alexandre Chojnowski; Nicole Ravisé; Corinne Bachelin; Christel Depienne; Merle Ruberg; Bernard Brugg; Jocelyn Laporte; Anne Baron-Van Evercooren; Eric LeGuern
Journal:  Neurobiol Dis       Date:  2007-01-25       Impact factor: 5.996

2.  An in vitro recombination method to convert restriction- and ligation-independent expression vectors.

Authors:  Feng Guo; Ming-Yi Chiang; Yingtong Wang; Yu-Zhu Zhang
Journal:  Biotechnol J       Date:  2008-03       Impact factor: 4.677

3.  Differential Sox10 genomic occupancy in myelinating glia.

Authors:  Camila Lopez-Anido; Guannan Sun; Matthias Koenning; Rajini Srinivasan; Holly A Hung; Ben Emery; Sunduz Keles; John Svaren
Journal:  Glia       Date:  2015-05-14       Impact factor: 7.452

4.  SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter.

Authors:  Chani J Hodonsky; Erica L Kleinbrink; Kira N Charney; Megana Prasad; Seneca L Bessling; Erin A Jones; Rajini Srinivasan; John Svaren; Andrew S McCallion; Anthony Antonellis
Journal:  Mol Cell Neurosci       Date:  2011-10-19       Impact factor: 4.314

5.  Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.

Authors:  Philipp Berger; Sonja Bonneick; Susan Willi; Matthias Wymann; Ueli Suter
Journal:  Hum Mol Genet       Date:  2002-06-15       Impact factor: 6.150

6.  Expression of the myelin-associated glycoprotein in cultures of immortalized Schwann cells.

Authors:  S Goda; J Hammer; D Kobiler; R H Quarles
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

7.  Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients.

Authors:  Y Su; D G Brooks; L Li; J Lepercq; J A Trofatter; J V Ravetch; R V Lebo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

9.  Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome.

Authors:  Anthony Antonellis; William R Bennett; Trevelyan R Menheniott; Arjun B Prasad; Shih-Queen Lee-Lin; Eric D Green; Derek Paisley; Robert N Kelsh; William J Pavan; Andrew Ward
Journal:  Hum Mol Genet       Date:  2005-12-05       Impact factor: 6.150

10.  Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings.

Authors:  Annalisa Bolis; Silvia Coviello; Simona Bussini; Giorgia Dina; Celia Pardini; Stefano Carlo Previtali; Mariachiara Malaguti; Paolo Morana; Ubaldo Del Carro; Maria Laura Feltri; Angelo Quattrini; Lawrence Wrabetz; Alessandra Bolino
Journal:  J Neurosci       Date:  2005-09-14       Impact factor: 6.167

View more
  2 in total

1.  Stringent comparative sequence analysis reveals SOX10 as a putative inhibitor of glial cell differentiation.

Authors:  Chetna Gopinath; William D Law; José F Rodríguez-Molina; Arjun B Prasad; Lingyun Song; Gregory E Crawford; James C Mullikin; John Svaren; Anthony Antonellis
Journal:  BMC Genomics       Date:  2016-11-07       Impact factor: 3.969

2.  SOX10-regulated promoter use defines isoform-specific gene expression in Schwann cells.

Authors:  Elizabeth A Fogarty; Jacob O Kitzman; Anthony Antonellis
Journal:  BMC Genomics       Date:  2020-08-08       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.